Regeneron Pharmaceuticals, Inc. Company Profile
Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates in Phase 3 clinical trials for the potential treatment of gout, diseases of the eye (wet age-related macular degeneration and central retinal vein occlusion), and certain cancers. Additional therapeutic candidates are in earlier stage development programs in rheumatoid arthritis and other inflammatory conditions, pain, cholesterol reduction, allergic and immune conditions and cancer. Additional information about Regeneron and recent news releases are available on the Regeneron web site at www.regeneron.com.
News Articles
Regeneron Pharmaceuticals expands ophthalmology portfolio
Regeneron Pharmaceuticals, Inc. today announced that it has expanded its ophthalmology portfolio by acquiring full exclusive rights to two families of novel antibodies invented at Regeneron and previo...
BRIEF-S&P 500 to add Regeneron, drop MetroPCS
April 24 (Reuters) - * S&P says to add Regeneron Pharmaceuticals Inc to S&P 500 * S&P says Regeneron to replace MetroPCS Communications Inc which is
Sanofi acquires undisclosed common stock from Regeneron Pharmaceuticals
Sanofi intends to acquire Common Stock of Regeneron through open market purchases and direct purchases from shareholders. As a result, Sanofi intends that the value of its ownership of voting securiti...
Regeneron: Solid Q1 Creates Platform For Further Upside
ByPropThink: By Ivan Deryugin Since our original report on Regeneron Pharmaceuticals (REGN) in mid-December, shares of the company have rallied over 47%, vs. a rise of over 27% for the Nasdaq Biotec...
Why Regeneron May Not Profit Much From Today’s FDA Approval
The Food and Drug Administration just announced that it approved Zaltrap for colorectal cancer, giving Tarrytown, N.Y.-based Regeneron its third approved drug — an impressive achievement. . Rege...
Regeneron says Sanofi plans to buy shares
Feb 11 (Reuters) - Regeneron Pharmaceuticals Inc on Monday said it has received notice that Sanofi SA intends to acquire Regeneron's common stock through open market purchases and direct purchases fr...
CORRECTED-Regeneron says Sanofi plans to buy shares
Feb 11 (Reuters) - Regeneron Pharmaceuticals Inc on Monday said it has received notice that Sanofi SA intends to acquire Regeneron's common stock through open market purchases and direct purchases fr...
Sanofi acquisition of Regeneron a possibility?
Acquisition possibility? Sanofi and Regeneron are already partners with CEO Chris Viehbachers intent on new deals. It started with Sanofi, a top pharma company based in France, purchasing enough Regen...
Drugs and Medications
Eylea [Regeneron Pharmaceuticals, Inc.]
These highlights do not include all the information needed to use EYLEA safely and effectively. See full prescribing information for EYLEA. EYLEA (aflibercept) Injection For Intravitreal Injection Ini...
Arcalyst [Regeneron Pharmaceuticals, Inc.]
These highlights do not include all the information needed to use ARCALYST safely and effectively. See full prescribing information for ARCALYST. ARCALYST (rilonacept)Injection for Subcutaneous UseIni...
PubMed Articles
In November 2011, aflibercept (Eylea; Regeneron Pharmaceuticals), a recombinant fusion protein that binds to members of the vascular endothelial growth factor family, was approved by the US Food and D...
Pharmacological inhibition of VEGF-A has proven to be effective in inhibiting angiogenesis and vascular leak associated with cancers and various eye diseases. However, little information is currently...
Ongoing Dll4-Notch signaling is required for T-cell homeostasis in adult thymus.
The essential role of the Delta-like ligand-4 (Dll4)-Notch signaling pathway in T lymphocyte development is well established. It has been shown that specific inactivation of Dll4 on thymic stromal cel...
Dupilumab in Persistent Asthma with Elevated Eosinophil Levels.
Background Moderate-to-severe asthma remains poorly treated. We evaluated the efficacy and safety of dupilumab (SAR231893/REGN668), a fully human monoclonal antibody to the alpha subunit of the interl...
Clinical Trials
Internleukin-1 Trap to Treat Autoinflammatory Disease
Autoinflammatory diseases are illnesses characterized by episodes of inflammation that, unlike autoimmune disorders, lack the production of high titer autoantibodies or antigen-specific T...
Companies
Regeneron Pharmaceuticals, Inc.
Regeneron is a fully integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST® (rilonacept...
Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candida...
Regeneron has several product candidates progressing through all stages of human clinical trials, for the potential treatment of a diverse set of diseases, including cancer, eye diseases, and inflamma...
ARTEMIS Pharmaceuticals, based in Cologne Germany was founded in 1998 and has made significant advances to provide rapid, efficient and sophisticated techniques for the analysis of gene function in ve...
Dr. C. Anthony Altar is President and Chief Scientific Officer at Psychiatric Genomics. His research team is responsible for gene discovery, medicinal chemistry, and drug discovery efforts. Dr. Altar...
More Information about "Regeneron Pharmaceuticals, Inc." on BioPortfolio
We have published hundreds of Regeneron Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Regeneron Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Regeneron Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Regeneron Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Regeneron Pharmaceuticals, Inc. Drugs and Medications on this site too.
